LONDON (Reuters) – AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row that has dogged the drug maker and Brussels this year.
The company is in talks with the EU, Ruud Dobber, executive vice president of the BioPharmaceuticals business, said on a briefing.
“We’re hopeful in the next few weeks we will have a settlement,” he said without giving further details.
(Reporting by Alistair Smout and Pushkala Aripaka; Editing by Alex Richardson; Writing by Josephine Mason)
